{"uid":"689d11b806c981cd","name":"TEST-SPO-116378.01","historyId":"METTA-WAM-ISSUE-116:METTA-WAM-ISSUE-116#TEST-SPO-116378.01","time":{"start":1728079929000,"stop":1728079975049,"duration":46049},"status":"passed","flaky":false,"newFailed":false,"newBroken":false,"newPassed":false,"retriesCount":0,"retriesStatusChange":false,"beforeStages":[],"testStage":{"steps":[{"name":"<![CDATA[","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"<a href=\"https://trueagi-io.github.io/metta-wam/reports/tests_output/baseline-compat/tests/baseline_compat/anti-regression/issues/metta-wam-issue-116/test_spo_116378.metta.0_failed.html#METTA-WAM-ISSUE-116.TEST-SPO-116378.01\">Test Report</a>","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"Assertion: (assertEqualToResult (match &hald116378 (Doxorubicin $p $o) (Doxorubicin $p $o)))","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"Expected: ((Doxorubicin needed Cardiotoxicity) (Doxorubicin treat Rituximab) (Doxorubicin prolong Neoplasms) (Doxorubicin show Drug-Related_Side_Effects_and_Adverse_Reactions) (Doxorubicin show Neoplasms) (Doxorubicin show Glioma) (Doxorubicin exhibit Drug-Related_Side_Effects_and_Adverse_Reactions) (Doxorubicin exhibit Neoplasms) (Doxorubicin accumulate Brain_Neoplasms) (Doxorubicin monitor Neoplasms) (Doxorubicin sever Drug-Related_Side_Effects_and_Adverse_Reactions) (Doxorubicin given Hemangiosarcoma) (Doxorubicin differ Drug-Related_Side_Effects_and_Adverse_Reactions) (Doxorubicin elevated Trastuzum...(3194)","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"Actual: ((Doxorubicin stratify Liposarcoma) (Doxorubicin associated MIR375) (Doxorubicin elevated Trastuzumab) (Doxorubicin include Trastuzumab) (Doxorubicin associated Cardiotoxicity) (Doxorubicin accepted 'Lymphoma,_B-Cell') (Doxorubicin represent Breast_Neoplasms) (Doxorubicin combine Breast_Neoplasms) (Doxorubicin fit Breast_Neoplasms) (Doxorubicin lead Death) (Doxorubicin cause Cardiotoxicity) (Doxorubicin stimulate Ischemia) (Doxorubicin induce CDKN2A) (Doxorubicin affect Cardiomyopathies) (Doxorubicin evaluate CAT) (Doxorubicin evaluate GSR) (Doxorubicin evaluate Lipid_Peroxides) (Doxorubicin e...(3194)","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"]]>","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false}],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":7,"attachmentsCount":0,"hasContent":true,"attachmentStep":false},"afterStages":[],"labels":[{"name":"resultFormat","value":"junit"},{"name":"suite","value":"METTA-WAM-ISSUE-116"},{"name":"testClass","value":"METTA-WAM-ISSUE-116"},{"name":"package","value":"METTA-WAM-ISSUE-116"}],"parameters":[],"links":[],"hidden":false,"retry":false,"extra":{"severity":"normal","retries":[],"categories":[],"history":{"statistic":{"failed":0,"broken":0,"skipped":0,"passed":24,"unknown":0,"total":24},"items":[{"uid":"2aed7be919b72bc9","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/294//#testresult/2aed7be919b72bc9","status":"passed","time":{"start":1728075697000,"stop":1728075743095,"duration":46095}},{"uid":"723cc0de724265f9","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/293//#testresult/723cc0de724265f9","status":"passed","time":{"start":1728020017000,"stop":1728020063146,"duration":46146}},{"uid":"babc990ce30f3bea","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/292//#testresult/babc990ce30f3bea","status":"passed","time":{"start":1728019432000,"stop":1728019478479,"duration":46479}},{"uid":"dad86e395c46ba5b","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/291//#testresult/dad86e395c46ba5b","status":"passed","time":{"start":1728018121000,"stop":1728018169014,"duration":48014}},{"uid":"6ca3614c1962c45b","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/289//#testresult/6ca3614c1962c45b","status":"passed","time":{"start":1728004244000,"stop":1728004290037,"duration":46037}},{"uid":"f3ca883ae2b9eb0b","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/288//#testresult/f3ca883ae2b9eb0b","status":"passed","time":{"start":1728003959000,"stop":1728004005642,"duration":46642}},{"uid":"a437f7530372d91e","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/287//#testresult/a437f7530372d91e","status":"passed","time":{"start":1728003078000,"stop":1728003124291,"duration":46291}},{"uid":"9729f0f716b6e22","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/286//#testresult/9729f0f716b6e22","status":"passed","time":{"start":1728001654000,"stop":1728001700525,"duration":46525}},{"uid":"ab474b2aa92b1bc6","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/285//#testresult/ab474b2aa92b1bc6","status":"passed","time":{"start":1728000801000,"stop":1728000846799,"duration":45799}},{"uid":"a4ad3c894a5e2a88","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/284//#testresult/a4ad3c894a5e2a88","status":"passed","time":{"start":1727976671000,"stop":1727976716710,"duration":45710}},{"uid":"9be3d759fd127bab","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/280//#testresult/9be3d759fd127bab","status":"passed","time":{"start":1727674850000,"stop":1727674896474,"duration":46474}},{"uid":"4db30d81cdb004f0","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/279//#testresult/4db30d81cdb004f0","status":"passed","time":{"start":1727663713000,"stop":1727663758844,"duration":45844}},{"uid":"cc7e762a216b444a","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/278//#testresult/cc7e762a216b444a","status":"passed","time":{"start":1727663517000,"stop":1727663563320,"duration":46320}},{"uid":"c3e17782e00e9b08","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/276//#testresult/c3e17782e00e9b08","status":"passed","time":{"start":1727608751000,"stop":1727608796977,"duration":45977}},{"uid":"d77b3ff8ad0e4b60","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/275//#testresult/d77b3ff8ad0e4b60","status":"passed","time":{"start":1727596304000,"stop":1727596350189,"duration":46189}},{"uid":"aee46f4ed38689c4","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/273//#testresult/aee46f4ed38689c4","status":"passed","time":{"start":1727518674000,"stop":1727518723251,"duration":49251}},{"uid":"51cab66ea84baf40","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/272//#testresult/51cab66ea84baf40","status":"passed","time":{"start":1727514046000,"stop":1727514093030,"duration":47030}},{"uid":"e87e52123b42ec38","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/271//#testresult/e87e52123b42ec38","status":"passed","time":{"start":1727513882000,"stop":1727513927926,"duration":45926}},{"uid":"7984358b506b41bc","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/270//#testresult/7984358b506b41bc","status":"passed","time":{"start":1727489952000,"stop":1727490000396,"duration":48396}},{"uid":"bee3ae71f5b52fe5","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/268//#testresult/bee3ae71f5b52fe5","status":"passed","time":{"start":1727481371000,"stop":1727481416941,"duration":45941}}]},"tags":[]},"source":"689d11b806c981cd.json","parameterValues":[]}